GO:0001890 placenta development: Trophoblast Differentiation and Vascular Remodeling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001890 placenta development describes the progression of the placenta from formation to a mature organ of metabolic interchange between fetus and mother.
• The process depends on coordinated trophoblast differentiation, invasion, spiral artery remodeling, and maternal immune tolerance.
• Key molecular drivers include HIF1A, EPAS1, FLT1, ENG, and GCM1, which regulate trophoblast lineage specification and placental angiogenesis.
• Disrupted placenta development underlies preeclampsia, fetal growth restriction, and placenta accreta spectrum.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of placental genes in trophoblast and stem-cell systems.
• Multi-omics and imaging methods, including single-cell RNA-seq and spatial transcriptomics, are increasingly used to map placental development in health and disease.
Description
GO:0001890 placenta development is the biological process by which the placenta forms and matures into an organ of metabolic interchange between the fetus and the mother. The placenta is partly of embryonic origin and partly of maternal origin, and its development requires tightly coordinated trophoblast differentiation, invasion into the maternal decidua, and remodeling of maternal spiral arteries. Because the placenta mediates gas exchange, nutrient transport, and hormone production, defects in its development are directly linked to major pregnancy complications. Researchers study placenta development to understand early human development, to model trophoblast lineage commitment, and to identify molecular targets for pregnancy disorders such as preeclampsia and fetal growth restriction. The process is also relevant to stem cell biology, since human trophoblast stem cells and induced trophoblast models now allow mechanistic dissection of placental gene function.
placenta development At A Glance
| GO ID | GO:0001890 |
|---|---|
| GO term | placenta development |
| Ontology | biological_process |
| Synonym | placental development; placentation |
| Major function | Progression of the placenta from formation to a mature organ of metabolic interchange between fetus and mother |
| Embryonic contribution | Trophoblast-derived cells, including cytotrophoblast, syncytiotrophoblast, and extravillous trophoblast |
| Maternal contribution | Decidual cells, immune cells, and spiral artery remodeling |
| Key molecular regulators | HIF1A, EPAS1, FLT1, ENG, GCM1, and related transcription factors |
| Associated disorders | Preeclampsia, fetal growth restriction, placenta accreta spectrum |
What Is GO:0001890?
In your own words, GO:0001890 placenta development is the set of cellular and molecular events through which the placenta progresses from its initial formation to a mature, functional organ. It encompasses trophoblast specification, proliferation, differentiation, syncytialization, invasion, vascular remodeling, and establishment of the maternal-fetal interface, resulting in a structure that supports metabolic exchange between fetus and mother.
Why Is placenta development Important in Cell Biology?
Placenta development is essential because the placenta is the primary interface for fetal nutrition, gas exchange, and immune protection, and its failure is a major cause of maternal and fetal morbidity. Understanding GO:0001890 therefore informs the molecular basis of pregnancy complications, the biology of trophoblast stem cells, and the development of experimental models for human placental disease.
• Defects in placenta development contribute to preeclampsia and fetal growth restriction.
• Abnormal trophoblast invasion is central to placenta accreta spectrum disorders.
• Placental development regulates maternal spiral artery remodeling and uteroplacental blood flow.
• Trophoblast differentiation is a model for stem cell lineage commitment and cell fusion.
• Placental gene expression influences fetal programming and long-term offspring health.
• Human trophoblast stem cells and organoids enable functional studies of placental genes.
• Placental pericytes contribute to vascular stability and homeostasis.
• Long noncoding RNAs such as H19 modulate placental development and ovarian biology.
• Placental development is a target for reproductive toxicology and drug safety assessment.
• Comparative and single-cell studies reveal conserved and human-specific placental mechanisms.
What Happens During placenta development?
Trophoblast specification and early placental formation
In simple terms: The outer cells of the early embryo become the placenta-forming cells.
After implantation, trophectoderm-derived cells commit to the trophoblast lineage and generate cytotrophoblast progenitors that self-renew and differentiate. This early specification depends on transcription factors and signaling pathways that establish the placental progenitor pool. Human trophoblast stem cell models have been used to dissect these early commitment events.
Syncytialization and hormone production
In simple terms: Some placental cells fuse to form a multinucleated layer that makes pregnancy hormones.
Cytotrophoblasts fuse to form the syncytiotrophoblast, a multinucleated layer that mediates nutrient and gas exchange and produces hormones such as human chorionic gonadotropin. Syncytialization requires fusion proteins and transcriptional regulators, and its disruption is associated with placental dysfunction.
Extravillous trophoblast invasion and spiral artery remodeling
In simple terms: Placental cells invade the mother's uterine tissue and widen her blood vessels.
Extravillous trophoblasts migrate into the decidua and remodel maternal spiral arteries to establish adequate uteroplacental blood flow. This invasion is tightly regulated, and excessive or insufficient invasion contributes to placenta accreta spectrum or preeclampsia, respectively.
Villous tree formation and vascularization
In simple terms: The placenta builds a branching tree of villi with blood vessels inside.
Placental villi form a branched structure that increases surface area for exchange, and fetal blood vessels develop within the villous core. Angiogenic factors such as FLT1 and ENG regulate this vascularization, and their imbalance is linked to placental insufficiency.
Maternal immune tolerance and decidual interaction
In simple terms: The mother's immune system must accept the placenta rather than reject it.
Decidual immune cells, including natural killer cells and macrophages, interact with trophoblasts to promote tolerance and vascular remodeling. Disruption of this dialogue is associated with pregnancy loss and preeclampsia.
Key Genes Involved in GO:0001890 placenta development
The following genes and proteins are established contributors to placenta development and are commonly studied in trophoblast and placental model systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HIF1A | Hypoxia-responsive transcription factor regulating trophoblast invasion and angiogenesis | Knockout and point-mutation models to test oxygen-sensing in trophoblast differentiation |
| EPAS1 | Hypoxia-inducible factor involved in placental vascular development | Knock-in reporter models to track expression during placental development |
| FLT1 | Soluble receptor that modulates VEGF signaling and placental angiogenesis | Overexpression and knockout models for preeclampsia-like phenotypes |
| ENG | TGF-beta co-receptor regulating trophoblast invasion and vascular remodeling | Knockout models to study preeclampsia-associated pathways |
| GCM1 | Transcription factor required for syncytiotrophoblast differentiation | Knockout and tagged knock-in models for syncytialization studies |
| TFAP2A | Transcription factor regulating trophoblast lineage specification | Knockout models to assess early placental development |
| CDX2 | Trophoblast lineage-associated transcription factor | Overexpression and knockout models in stem cell systems |
| KRT7 | Cytokeratin marker of trophoblast cells | Tagged knock-in for lineage tracing |
| GATA3 | Transcription factor important for trophoblast differentiation | Knockout models to study trophoblast commitment |
| H19 | Long noncoding RNA implicated in placental development | Knockout and overexpression models for placental growth |
| VEGFA | Angiogenic factor regulating placental vascularization | Knock-in and overexpression models for vascular studies |
| PGF | Placental growth factor modulating angiogenesis | Knockout models for placental vascular phenotypes |
| MMP2 | Matrix metalloproteinase involved in trophoblast invasion | Knockout models for invasion assays |
| MMP9 | Matrix metalloproteinase contributing to extracellular matrix remodeling | Knockout and point-mutation models for invasion studies |
| ITGA1 | Integrin mediating trophoblast-decidua interactions | Knock-in and knockout models for adhesion studies |
| NOTCH1 | Signaling receptor regulating trophoblast differentiation | Knockout models for lineage specification |
| WNT7A | Wnt ligand implicated in placental development | Overexpression models for pathway activation |
| PDGFB | Growth factor supporting placental pericyte and vascular development | Knockout models for pericyte function |
How Is placenta development Regulated?
Placenta development is regulated by oxygen tension, growth factor signaling, and transcriptional networks. Hypoxia-inducible factors such as HIF1A and EPAS1 mediate responses to low oxygen in the early placenta and regulate trophoblast invasion and angiogenesis. VEGF, FLT1, and ENG signaling control vascular remodeling, and their imbalance is associated with preeclampsia. Transcription factors including GCM1 and TFAP2A coordinate syncytialization and lineage specification. Long noncoding RNAs such as H19 also modulate placental development. Immune and decidual signals further regulate trophoblast invasion and maternal tolerance.
placenta development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FLT1 | Preeclampsia and placental angiogenesis imbalance | Overexpression and knockout trophoblast models |
| ENG | Preeclampsia and vascular remodeling defects | Knockout and point-mutation models |
| HIF1A | Hypoxia-related placental dysfunction | Knockout and knock-in reporter models |
| GCM1 | Syncytialization defects and placental insufficiency | Knockout and tagged knock-in models |
| H19 | Placental growth abnormalities | Knockout and overexpression models |
Preeclampsia
Preeclampsia is associated with abnormal trophoblast invasion, impaired spiral artery remodeling, and an imbalance of angiogenic factors such as FLT1 and ENG. These defects reflect disrupted placenta development and lead to maternal hypertension and fetal complications.
Fetal growth restriction
Fetal growth restriction often results from placental insufficiency, including reduced villous vascularization and altered trophoblast differentiation. Molecular studies of placenta development have identified pathways that contribute to impaired nutrient and oxygen delivery.
Placenta accreta spectrum
Placenta accreta spectrum is characterized by excessive trophoblast invasion and abnormal adherence to the myometrium, reflecting dysregulated invasive pathways in placenta development. Understanding the pathophysiology supports improved prenatal imaging and clinical management.
Placental dysfunction in other pregnancy disorders
Disrupted placenta development has been linked to miscarriage, preterm birth, and other pregnancy complications through mechanisms involving trophoblast differentiation, immune tolerance, and vascular remodeling.
From placenta development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate trophoblast invasion? | Knockout in human trophoblast stem cells or organoids |
| Does a point mutation alter syncytialization? | Point-mutation knock-in in trophoblast cell lines |
| Where is a placental gene expressed during development? | Tagged knock-in reporter models |
| Does overexpression of an angiogenic factor cause preeclampsia-like phenotypes? | Overexpression in trophoblast and mouse models |
| What is the role of a long noncoding RNA in placental growth? | Knockout and overexpression models |
| How do pericytes support placental vasculature? | Knockout and lineage-tracing models |
How to Study the placenta development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Cell-type-specific gene expression in placenta | Mapping trophoblast lineages and disease states |
| Spatial transcriptomics | Gene expression with tissue context | Localizing placental gene expression |
| Immunohistochemistry | Protein localization in placental tissue | Assessing trophoblast invasion and villous structure |
| Trophoblast stem cell assays | Differentiation and invasion capacity | Functional testing of candidate genes |
| Proteomics | Protein abundance and secretome composition | Identifying biomarkers of placental dysfunction |
| CRISPR screening | Gene function at scale | Discovering regulators of trophoblast phenotypes |
| Reporter assays | Transcriptional activity of placental genes | Testing regulatory elements and mutations |
| Organoid culture | 3D placental tissue architecture | Modeling placental development and disease |
Single-cell and spatial transcriptomics
Single-cell RNA sequencing and spatial transcriptomics map trophoblast subtypes and their spatial organization in the placenta, revealing lineage trajectories and disease-associated changes.
Trophoblast stem cell and organoid models
Human trophoblast stem cells and placental organoids provide tractable systems for genetic perturbation and functional assays of placenta development genes.
Imaging and histology
Immunohistochemistry, in situ hybridization, and advanced imaging visualize trophoblast invasion, spiral artery remodeling, and villous architecture in tissue sections.
Proteomics and secretome analysis
Proteomic and secretome profiling identify placental factors such as FLT1 and PGF that are released into maternal circulation and associated with pregnancy disorders.
How CRISPR Can Be Used to Study GO:0001890 placenta development
Knockout
CRISPR knockout of placental genes in trophoblast stem cells or cell lines can reveal essential roles in differentiation, invasion, and syncytialization. Knockout models help determine whether a candidate gene is required for placenta development.
Point Mutation
Point-mutation knock-in can model disease-associated variants in placental genes and test their effects on protein function and trophoblast phenotypes.
Knock-in
Knock-in of reporters or tags enables lineage tracing and expression analysis of placental genes during development.
Overexpression
Overexpression of angiogenic or transcription factors can model placental dysfunction and test gain-of-function mechanisms in trophoblast systems.
How EDITGENE Supports placenta development Research
Researchers studying placenta development-related genes often need to determine whether a candidate gene is causally involved in trophoblast differentiation, invasion, or vascular remodeling. EDITGENE provides CRISPR-based cell model services that enable functional testing of placental genes in relevant cellular systems.
Contact EDITGENE today to design your custom CRISPR model for placenta development research.
Frequently Asked Questions About placenta development
What is placenta development GO:0001890?
GO:0001890 placenta development is the biological process by which the placenta progresses from formation to a mature organ of metabolic interchange between fetus and mother.
What genes are involved in placenta development?
Key genes include HIF1A, EPAS1, FLT1, ENG, GCM1, TFAP2A, and H19, among others.
What are the main stages of placenta development?
Major stages include trophoblast specification, syncytialization, extravillous trophoblast invasion, spiral artery remodeling, and villous vascularization.
How is placenta development studied?
It is studied using trophoblast stem cells, organoids, single-cell RNA-seq, spatial transcriptomics, imaging, and CRISPR perturbation.
What diseases are linked to abnormal placenta development?
Preeclampsia, fetal growth restriction, and placenta accreta spectrum are linked to disrupted placenta development.
What is the role of trophoblast invasion in placenta development?
Extravillous trophoblasts invade the decidua and remodel maternal spiral arteries to establish uteroplacental blood flow.
How do CRISPR models help study placenta development?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of placental gene function in trophoblast systems.
What is the difference between placenta development and placentation?
Placentation is a synonym for placenta development, describing the same process of placental formation and maturation.
Which cell types are important in placenta development?
Cytotrophoblasts, syncytiotrophoblast, extravillous trophoblasts, decidual cells, and immune cells are important.
Why is placenta development important for pregnancy health?
Because the placenta mediates fetal nutrition and gas exchange, and its dysfunction causes major pregnancy complications.
Conclusion
GO:0001890 placenta development is a central biological process that integrates trophoblast differentiation, invasion, vascular remodeling, and maternal immune tolerance to build the maternal-fetal interface. Its disruption underlies major pregnancy disorders, making it a key area for mechanistic and translational research. CRISPR-based cell models and multi-omics approaches now provide powerful tools to dissect placental gene function and identify therapeutic targets.
References
- 1. Knöfler M et al.. 2019. Human placenta and trophoblast development: key molecular mechanisms and model systems.. Cell Mol Life Sci 76(18):3479-3496 PMID: 31049600
- 2. Jauniaux E et al.. 2018. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.. Am J Obstet Gynecol 218(1):75-87 PMID: 28599899
- 3. Sun C et al.. 2020. The placenta in fetal growth restriction: What is going wrong?. Placenta 96:10-18 PMID: 32421528
- 4. Aplin JD et al.. 2020. Tracking placental development in health and disease.. Nat Rev Endocrinol 16(9):479-494 PMID: 32601352
- 5. Quaye D et al.. 2026. The human placenta development and anatomy.. Arch Gynecol Obstet 313(1) PMID: 42204027
- 6. Gauster M et al.. 2022. Early human trophoblast development: from morphology to function.. Cell Mol Life Sci 79(6):345 PMID: 35661923
- 7. Barreto RSN et al.. 2019. Pericytes in the Placenta: Role in Placental Development and Homeostasis.. Adv Exp Med Biol 1122:125-151 PMID: 30937867
- 8. Adu-Gyamfi EA et al.. 2024. Long noncoding RNA H19 in ovarian biology and placenta development.. Cell Biochem Funct 42(1):e3907 PMID: 38269505
